about
Development of a single vector system that enhances trans-splicing of SMN2 transcriptsModeling spinal muscular atrophy in DrosophilaSurvival motor neuron protein regulates stem cell division, proliferation, and differentiation in DrosophilaCoiled bodies and gems: Janus or gemini?Drug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIThe zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.The survival motor neuron protein forms soluble glycine zipper oligomersHeterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissuesA SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA miceCopy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative DiseasesMolecular Mechanisms of Neurodegeneration in Spinal Muscular AtrophyStem cell transplantation for motor neuron disease: current approaches and future perspectivesSkeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA)Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophyGenetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy.A large animal model of spinal muscular atrophy and correction of phenotype.Solution structure of the core SMN–Gemin2 complexThe SMN structure reveals its crucial role in snRNP assemblyThe neuroprotective drug riluzole acts via small conductance Ca2+-activated K+ channels to ameliorate defects in spinal muscular atrophy modelsArrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice.Deficiency of the zinc finger protein ZPR1 causes neurodegenerationSelective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense OligonucleotidesCandidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical studyUtility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analysesNeuron-specific knock-down of SMN1 causes neuron degeneration and death through an apoptotic mechanismInduced pluripotent stem cells from a spinal muscular atrophy patientStem cell-based models and therapies for neurodegenerative diseasesTranslational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivoA novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophyEffects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophyFasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophySMN is required for sensory-motor circuit function in Drosophila.The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models.Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.Pharmacokinetics, pharmacodynamics, and efficacy of a small-molecule SMN2 splicing modifier in mouse models of spinal muscular atrophy
P2860
Q21092173-3FC1BB83-FA8F-4792-9BD2-C1A05DB83E10Q21562542-A492E005-695F-4100-ACC8-BFD740A0FD77Q21563387-2BF8AF03-FEEB-486A-AB0C-B00DF368DD8CQ22066143-855DF90C-85DA-4131-8916-6F09FB06801DQ24200270-F4904C1C-8998-447E-BCB3-269B1BF854A3Q24200377-7A18F519-37F6-4F59-992E-9F780C2A65A0Q24234414-4AFA723E-50AE-4F57-993A-8D8E8B512DF6Q24234523-929DB1F1-D0C9-41CC-8CD6-DBCB0A1E1D48Q24241017-23CB6903-A1E5-4506-85FC-BF7555D847F0Q24241759-7CF14141-7179-40F8-A20B-11FA85C3BF75Q24307665-259DB182-21D6-4CAC-A8DC-4BE3239614BFQ24600623-E8E9CD37-FFE4-40E2-BABE-FEB6012767E2Q24651106-5898C247-0CED-4312-BA85-B6F3336B9B99Q24657021-6D0CF059-E1B0-4417-B072-0A443D0DCCF6Q26750803-39142302-1125-4756-932D-ED6393362461Q26752798-3564B7E5-259E-4561-B44F-CBD7C3B7F570Q26995278-4911BBB9-4523-423B-A6FB-4ADDA69669D4Q27312220-E6D4DBBF-DBCC-4326-BFBB-D574EE7137C5Q27312456-99514BE6-400A-453C-A1AA-7F10352EEBB5Q27328843-F0A86145-8FA6-4463-A495-0AB7E053E389Q27340106-D6963717-8EA8-4551-87AF-DAE1BD42BB1EQ27679173-0D0847BA-55B6-4AFB-9DDA-4AC825404977Q28254957-8BE68551-00AF-467C-A8AA-DB9A511BEDFCQ28288745-E34AADC7-67DB-4881-8135-1C155B722826Q28289944-83CF21A3-4B09-48CB-944B-860B7728CF25Q28513750-49DD55C2-5E8F-4507-B4C1-7301C9957FF4Q28551647-3ADE6934-6672-4A62-910C-D26711BD643DQ28730283-78ECB7B5-4F7A-4D14-B712-0488034B096DQ28740896-F2AAA80B-0EBA-4D52-AF9A-EE65424C3402Q28818674-C785BC11-9A8C-4058-BA37-53215D9B9944Q29614340-4EC870E8-432B-46C5-84D7-10261C6908C9Q30451005-814A8FC9-4DA9-4ED8-B21F-B003EAECBEB3Q30486481-56D5C82B-E4D7-4F1B-BF09-271F4DDDFC98Q30488346-DC17081E-DE8D-4886-BA57-5C0AA61CBD17Q30492560-6C097BB0-F190-4EEF-9A50-454F125BE949Q30511954-8D6A0EC4-67CB-4DC1-A6F7-1519CEFACA50Q30525692-7FF0C23F-680D-445A-9522-E7882CF6DFAAQ30546337-69CB2A96-689C-41CE-BD63-4289C98CC185Q30702451-10AC3C3E-65FF-412B-9BC7-50AB1BF632C2Q30821687-5816ADEF-09D7-4112-8F7C-B63A8997FD11
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The neurobiology of childhood spinal muscular atrophy.
@en
type
label
The neurobiology of childhood spinal muscular atrophy.
@en
prefLabel
The neurobiology of childhood spinal muscular atrophy.
@en
P356
P1476
The neurobiology of childhood spinal muscular atrophy
@en
P2093
Crawford TO
P304
P356
10.1006/NBDI.1996.0010
P577
1996-04-01T00:00:00Z